The Gene Editing Market is witnessing a transformative phase driven by the sophisticated capabilities of advanced endonuclease platforms. These molecular tools, which allow for unparalleled precision in modifying genetic material, are the foundation of what is being called the therapeutic revolution. The initial success in applying these methods to address simple monogenic disorders has paved...